> Anatomy > Cell > Blood Cells

Blood Cells

Blood cells, also known as hematopoietic cells, are the cellular components of blood that play vital roles in the body's physiological processes.
These cells include red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes).
Red blood cells are responsible for transporting oxygen and carbon dioxide throughout the body, while white blood cells defend against infection and disease.
Platelets are essential for blood clotting and wound healing.
Researchers in the field of blood cell research utilize advanced techniques and technologies to study the structure, function, and development of these critical cellular components.
Accurate and reproducible protocols are crucial for advancing our understanding of blood cell biology and improving clinical applications.

Most cited protocols related to «Blood Cells»

RNA-seq Data Preprocessing and Immune Cell Quantification

FASTQ files of RNA-seq reads were pre-processed with Trimmomatic [22 (link)] to remove adapter sequences and read ends with Phred quality scores lower than 20, to discard reads shorter than 36 bp, and to trim long reads to a maximum length of 50 bp. This analysis is implemented in the “Preprocessing” module of quanTIseq (step 1 in Fig. 1c), which also allows selecting different parameters for data preprocessing.Fig. 1

quanTIseq method and validation based on blood-cell mixtures. a quanTIseq characterizes the immune contexture of human tumors from expression and imaging data. Cell fractions are estimated from expression data and then scaled to cell densities (cells/mm²) using total cell densities extracted from imaging data. b Heatmap of quanTIseq signature matrix, with z scores computed from log₂(TPM+1) expression values of the signature genes. c The quanTIseq pipeline consists of three modules that perform (1) pre-processing of paired- or single-end RNA-seq reads in FASTQ format; (2) quantification of gene expression as transcripts-per-millions (TPM) and gene counts; and (3) deconvolution of cell fractions and scaling to cell densities considering total cells per mm² derived from imaging data. The analysis can be initiated at any step. Optional files are shown in grey. Validation of quanTIseq with RNA-seq data from blood-derived immune cell mixtures generated in [46 (link)] (d) and in this study (e). Deconvolution performance was assessed with Pearson’s correlation (r) and root-mean-square error (RMSE) using flow cytometry estimates as ground truth. The grey and blue lines represent the linear fit and the “x = y” line, respectively. B, B cells; CD4, non-regulatory CD4⁺ T cells; CD8, CD8⁺ T cells; DC, dendritic cells; M1, classically activated macrophages; M2, alternatively activated macrophages; Mono, monocytes; Neu, neutrophils; NK, natural killer cells; T, T cells; Treg, regulatory T cells

Finotello F., Mayer C., Plattner C., Laschober G., Rieder D., Hackl H., Krogsdam A., Loncova Z., Posch W., Wilflingseder D., Sopper S., Ijsselsteijn M., Brouwer T.P., Johnson D., Xu Y., Wang Y., Sanders M.E., Estrada M.V., Ericsson-Gonzalez P., Charoentong P., Balko J., de Miranda N.F, & Trajanoski Z. (2019). Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Medicine, 11, 34.

Full text: Click here

Publication 2019

B-Lymphocytes Blood Cells CD8-Positive T-Lymphocytes Cells Dendritic Cells Flow Cytometry Gene Expression Genes Homo sapiens Macrophage Monocytes Natural Killer Cells Neoplasms Neutrophil Plant Roots Regulatory T-Lymphocytes RNA-Seq T-Lymphocyte

Fast-ATAC Sequencing of Sorted Cells

This protocol has been optimized for blood cells. We note that digitonin is a gentle detergent and this protocol may not be ideal for cell lines and other cell types that are more resistant to lysis. 5,000 sorted cells in FACS Buffer were pelleted by centrifugation at 500 RCF for 5 minutes at 4C in a pre-cooled fixed-angle centrifuge. All supernatant was removed using two pipetting steps being careful to not disturb the not visible cell pellet. 50 ul transposase mixture (25 ul of 2x TD buffer, 2.5 ul of TDE1, 0.5 ul of 1% digitonin, 22 ul of nuclease-free water) (Cat# FC-121-1030, Illumina; Cat# G9441, Promega) was added to the cells and the pellet was disrupted by pipetting. Transposition reactions were incubated at 37°C for 30 minutes in an Eppendorf ThermoMixer with agitation at 300 RPM. Transposed DNA was purified using a QIAgen MinElute Reaction Cleanup kit (Cat# 28204) and purified DNA was eluted in 10 ul elution buffer (10 mM Tris-HCl, pH 8). Transposed fragments were amplified and purified as described previously^{48 (link)} with modified primers^{23 (link)}. Libraries were quantified using qPCR prior to sequencing. All Fast-ATAC libraries were sequenced using paired-end, dual-index sequencing on a NextSeq with 76×8×8×76 cycle reads.

Corces M.R., Buenrostro J.D., Wu B., Greenside P.G., Chan S.M., Koenig J.L., Snyder M.P., Pritchard J.K., Kundaje A., Greenleaf W.J., Majeti R, & Chang H.Y. (2016). Lineage-specific and single cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nature genetics, 48(10), 1193-1203.

Publication 2016

Blood Cells Buffers Cell Lines Cells Centrifugation Detergents Digitonin Promega Transposase Tromethamine XCL1 protein, human

Derivation of Human iPSCs from Fibroblasts and Blood Cells

Human primary fibroblasts were derived from biopsied skin tissue samples. The fibroblasts were established and expanded with DMEM containing 10% autologous human serum. Using these fibroblasts, iPS cells were generated as described previously17 (link). Briefly, following electroporation of reprogramming factors with episomal vectors using the Neon system (Life Technologies), the cells were plated on a non-coated cell culture plate. iPS cells were induced by changing the medium to StemFit™. Twenty to thirty days after plating, iPS cell colonies were observed.
Blood cell-derived iPS cells were generated as described previously16 (link). Briefly, mononuclear cells were prepared from peripheral blood using the Ficoll-Paque PREMIUM (GE Healthcare) separation method. The cells were electroporated with episomal vectors using a Nucleofector 4D system (with P3 Primary Cell Kit, Lonza) and plated on rLN511E8-coated cell culture plates. The iPSCs were induced by changing the medium to StemFit™. Twenty to thirty days after plating, iPS cell colonies were observed. A similar method was used to generate Ff-hiPSCs from human cord blood (provided by the RIKEN Bioresource Center Cell Bank). We generated several clones of Ff-hiPSCs from each experiment.
The experimental protocols dealing with human subjects were approved by the institutional review board at our institute (Kyoto University Graduate School and Faculty of Medicine, Ethics Committee). Written informed consent was provided by each donor.

Nakagawa M., Taniguchi Y., Senda S., Takizawa N., Ichisaka T., Asano K., Morizane A., Doi D., Takahashi J., Nishizawa M., Yoshida Y., Toyoda T., Osafune K., Sekiguchi K, & Yamanaka S. (2014). A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Scientific Reports, 4, 3594.

Publication 2014

BLOOD Blood Cells Cell Culture Techniques Cells Clone Cells Cloning Vectors Electroporation Episomes Ethics Committees Ethics Committees, Research Faculty, Medical Fibroblasts Ficoll Homo sapiens Human Induced Pluripotent Stem Cells Induced Pluripotent Stem Cells Neon Serum Skin Tissue Donors Umbilical Cord Blood

Comparative Analysis of Collapsing Methods

For each of our examples, we ran a subset of the following six collapsing methods and studied how often each method leads to the most reproducible results. First, we choose the row with the highest mean expression (1.max) by setting method = "MaxMean" and connectivityBasedCollapsing = FALSE. Second, we choose the row with the highest between-column variability (2.var) by setting method = "maxRowVariance" and connectivityBasedCollapsing = FALSE. Third, we choose the row with the highest connectivity in cases with three or more rows per group or highest mean expression in cases with two rows per group (3.kMax) by setting method = "MaxMean" and connectivityBasedCollapsing = TRUE. Fourth, we choose the row with the highest connectivity in cases with three or more rows per group or maximum variability in cases with two rows per group (4.kVar) by setting method = "maxRowVariance" and connectivityBasedCollapsing = TRUE. Fifth, as a sort of control, we compare our results to a standard method of centroid determination by measuring the module eigengene (first principal component) for all rows in a given group across all groups (5.ME) by setting method = "ME". Finally, in our assessment of blood cell type, we also use the average of all marker genes (6.Avg) by setting method = "average".

Miller J.A., Cai C., Langfelder P., Geschwind D.H., Kurian S.M., Salomon D.R, & Horvath S. (2011). Strategies for aggregating gene expression data: The collapseRows R function. BMC Bioinformatics, 12, 322.

Full text: Click here

Publication 2011

Blood Cells Genes

Comprehensive Illumina 450k DNA Methylation Datasets

Below we give a brief summary of the datasets used in the construction of the reference databases (see also Table 1).Table 1

Main Illumina 450k DNAm datasets used. We list the main datasets used in this study, the cell-types/tissue profiled, whether the data was used for reference database construction (if yes, we specify which cell-types were used), whether the data was used for validation/evaluation purposes (if yes, we specify which cell-types were used) and the reference/citation

Dataset Name	Tissue/cell-types	Use in Reference DNAm Database	Testing/Evaluation	Reference
Reinius et al.	WB, PBMC, NK, B, CD4T, CD8T, Monoc, Neutro, Eosino. (n = 6 of each)	NK, B, CD4T, CD8T, Monoc., Neutro., Eosino.	WB & PBMC	[24 (link)]
Liu et al.	WB (n = 335 controls, n = 354 rheumathoid arthritis cases)	No	Average Flow Cytometry estimates for cases and controls	[2 (link)]
Koestler et al.	WB (n = 18)	No	12 Reconstructed WB mixtures + 6 WB samples with Flow Cytometry estimates	[20 (link)]
Zilbauer et al.	PBMC, CD4T, CD8T, NK, B, Monoc, Neutro. (n = 6 of each)	No	In-silico mixtures of purified blood cell subtypes	[27 (link)]
ENCODE	Various	HMEC, HRCE, IMR90, Liver	No	[22 (link)]
Slieker et al.	Various	Pancreas	Liver	[26 (link)]
SCM2	Various	No	HRCE, Pancreas, IMR90	[29 (link)]
Lowe et al.	Various	No	HMEC	[28 (link), 35 (link)]
Teschendorff et al.	WB (n = 152)	No	Smoking associated DMCs	[31 (link)]

Abbreviations: DNAm = DNA methylation, WB = whole blood, PBMC = peripheral blood mononuclear cells, HMEC = human mammary epithelial cells, HRCE = human renal cortical epithelia, IMR90 (fetal lung fibroblast), SCM2 = Stem-Cell-Matrix Compendium-2, DMCs = differentially methylated CpGs, NK = natural killer cells, B = B-cell, Monoc = Monocytes, Neutro. = Neutrophils, Eosino = Eosinophils, CD4T = CD4+ T-cells, CD8T = CD8+ T-cells

Teschendorff A.E., Breeze C.E., Zheng S.C, & Beck S. (2017). A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies. BMC Bioinformatics, 18, 105.

Full text: Click here

Publication 2017

Arthritis B-Lymphocytes BLOOD Blood Cells Breast CD4 Positive T Lymphocytes CD8-Positive T-Lymphocytes cytidylyl-3'-5'-guanosine DNA Methylation Eosinophil Epithelial Cells Epithelium Fetus Fibroblasts Flow Cytometry Homo sapiens Kidney Cortex Lung Monocytes Natural Killer Cells Neutrophil Pancreas PBMC Peripheral Blood Mononuclear Cells Stem Cells Tissues

Most recents protocols related to «Blood Cells»

Patient-Derived Organoid Drug Screening

Not available on PMC !

Example 4

As a non-limiting example, the perfusion chamber or the multi-well plate described herein can be used for drug screening. As shown in FIG. 19, skin or blood cells from human patients having a specific disease can be collected to generate patient-specific induced pluripotent stem cells (iPS cells). The iPS cells can be cultured in a dish to mimic disease-affected cells. Alternatively, the iPS cells can be stimulated to differentiate into an organoid sample, which can be used as a disease model. The organoid sample can be dissected and transferred into the perfusion chamber or the multi-well plate as described herein. Afterwards, the test compounds (e.g., drugs) can be diluted and used to treat the organoid sample in each chamber (or well) with proper controls. Cellular activities and/or intracellular gene expressions can be detected (e.g., recorded) in response to test compounds (e.g., drugs) treatment. The organoid sample can then be subjected to a spatial analysis workflow as described herein. Based on changes of the detected cellular activities and/or the intracellular gene expressions, together with the spatial analysis results, disease-specific drugs can be determined and used to treat the specific disease in the human patients.

US11866767B2. Simultaneous spatio-temporal measurement of gene expression and cellular activity (2024-01-09). 10x Genomics, Inc. [US]. Inventors: Cedric Uytingco [US], Layla Katiraee [US], Kristen Pham [US].

Full text: Click here

Patent 2024

Blood Cells Cells Gene Expression Homo sapiens Hyperostosis, Diffuse Idiopathic Skeletal Induced Pluripotent Stem Cells Organoids Patients Perfusion Pharmaceutical Preparations Protoplasm Skin

Optimizing Morphogen Exposure in Stem Cell Differentiation

Not available on PMC !

Example 6

Optimization of Morphogen Exposure

The optimal duration of caudalization and ventralization may vary depending on the parent cell line used, culture conditions, and quality of reagents. For cells with ESC origin both caudalization and ventralization are typically 1 day faster, for hiPSC derived from adult cells, the time can depend on the origin of the somatic cells. Several different types of cells have been used to produce iPSCs, including fibroblasts, neural progenitor cells, keratinocytes, melanocytes, CD34+ cells, hepatocytes, cord blood cells and adipose stem cells. In hiPSC derived from CD34+ cells caudalization and ventralization may be slower for up to 2 days. hiPSC derived from fibroblasts typically follow the time line as explained in the FIG. 1.

US11859206B2. Generation of oligodendrogenic neural progenitor cells (2024-01-02). UNIVERSITY HEALTH NETWORK [CA]. Inventors: Michael George Fehlings [CA], Mohamad Khazaei [CA].

Full text: Click here

Patent 2024

Adipocytes Adult Blood Cells Cell Lines Cells Cone-Rod Dystrophy 2 Fibroblasts Gene Therapy, Somatic Germ Cells Hepatocyte Human Induced Pluripotent Stem Cells Induced Pluripotent Stem Cells Keratinocyte Melanocyte Neural Stem Cells Neurogenesis Parent Stem, Plant TimeLine Umbilical Cord Blood

Transfection of Hematopoietic Cells

Not available on PMC !

Example 26

Blood cells, such as mature peripheral blood T lymphocytes, monocytes, macrophages, T cell progenitors, macrophage-monocyte progenitor cells, and/or pluripotent hematopoietic stem cells (such as those found in umbilical cord blood and occupying bone marrow spaces) as well as other stem/progenitor cells can be transfected using the therapeutic vector(s) in vitro. Appropriate concentrations of the therapeutic vector(s) may be those consistent with Browning et al., 1999. Subsequently, cells are expanded (propagated) in vitro, and are then transferred to the host via introduction of the cells to the venous or arterial circulation using an intravenous needle or catheter. Subsequently, cells transfected with the therapeutic vectors are able to “home” to the bone marrow and other tissues.

It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety for all purposes.

US11859168B2. Electroporation, developmentally-activated cells, pluripotent-like cells, cell reprogramming and regenerative medicine (2024-01-02). None [US]. Inventors: Christopher B. Reid [US], Melissa Braga [US], Lilian N. Santamaria [US], Ashley N. Wickrema [US], Marinne D. Wickrema [US], Anthony Hao Dinh [US], Yaman Eksioglu [US], Mat Hoang Ho [US].

Full text: Click here

Patent 2024

Arteries BLOOD Blood Cells Bone Marrow Catheters Cells Cloning Vectors Light Macrophage Monocytes Needles Stem Cells Stem Cells, Hematopoietic T-Lymphocyte Therapeutics Tissues Umbilical Cord Blood Veins

Extracting Hematopoietic Stem Cells from Blood

Not available on PMC !

Example 4

Extracting Haematopoietic Stem Cells from Peripheral Blood

Upon giving consent the donors are given a granulocyte-colony stimulating factor (G-CSF) and/or a granulocyte-macrophage colony-stimulating factor (GM-CSF), e.g. Neupogen® (commercially available from Amgen Inc. USA) to help harvest peripheral haematopoietic stem cells with minimal possible discomfort to donors. Cell surface polypeptide markers are used for identifying long-lasting multipotent stem-cells. Suitably markers may include CD 34⁺, CD59⁺, Thy1⁺, CD38^low/−, C-kit^−/low, and lin⁻.

US11878033B2. Cancer-killing cells (2024-01-23). LIFT BIOSCIENCES LTD [GB]. Inventors: Alex Blyth [GB], Nico Bruyniks [GB].

Full text: Click here

Patent 2024

Blood Cells CD59 protein, human Cells Donors Granulocyte-Macrophage Colony-Stimulating Factor Granulocyte Colony-Stimulating Factor Hematopoietic System Malignant Neoplasms Multipotent Stem Cells Neupogen Peripheral Blood Stem Cells Polypeptides Proto-Oncogene Protein c-kit Stem Cells, Hematopoietic

Metastatic Lung Tissue Dissociation

Lungs bearing metastasis were digested with a cocktail containing collagenase I (45 U/ml; Worthington), collagenase II (15 U/ml; Worthington), collagenase III (45 U/ml; Worthington), collagenase IV (45 U/ml; Worthington), elastase (0.075 U/ml; Worthington), hyaluronidase (30 U/ml; MilliporeSigma), and DNase type I (25 U/ml; MilliporeSigma) for 60 min at 37°C and passed through a 70-μm cell strainer (Falcon). Whole blood collected from tumor-bearing mice was spun at 2,000 rpm for 20 min at 4°C to collect the cell pellet. Cells from blood and lungs were washed with PBS and stained with Ghost Viability Dye 510 (BD Biosciences) for 15 min. Cells were then washed and stained with antibodies against CD11b (557657; BD Biosciences) and Ly-6G (740953; BD Biosciences) for 1 h at 4°C. Cells were analyzed using FACS LSRFortessa SORP (BD Biosciences) with the help of the Moody Foundation flow cytometry facility at UT Southwestern Medical Center. Analysis was performed using FlowJo software.

Ganguly D., Schmidt M.O., Coleman M., Ngo T.V., Sorrelle N., Dominguez A.T., Murimwa G.Z., Toombs J.E., Lewis C., Fang Y.V., Valdes-Mora F., Gallego-Ortega D., Wellstein A, & Brekken R.A. (2023). Pleiotrophin drives a prometastatic immune niche in breast cancer. The Journal of Experimental Medicine, 220(5), e20220610.

Full text: Click here

Publication 2023

Antibodies BLOOD Blood Cells Cells Collagenase Collagenase, Clostridium histolyticum Deoxyribonuclease I Flow Cytometry Hyaluronidase ITGAM protein, human Lung Mus Neoplasm Metastasis Neoplasms Pancreatic Elastase Red Cell Ghost

Top products related to «Blood Cells»

Facscanto 2 by BD

Sourced in United States, Germany, United Kingdom, Belgium, China, France, Australia, Japan, Italy, Spain, Switzerland, Canada, Uruguay, Netherlands, Czechia, Jersey, Brazil, Denmark, Singapore, Austria, India, Panama

The FACSCanto II is a flow cytometer instrument designed for multi-parameter analysis of single cells. It features a solid-state diode laser and up to four fluorescence detectors for simultaneous measurement of multiple cellular parameters.

Facscalibur by BD

Sourced in United States, Germany, United Kingdom, China, Canada, Japan, Italy, France, Belgium, Singapore, Uruguay, Switzerland, Spain, Australia, Poland, India, Austria, Denmark, Netherlands, Jersey, Finland, Sweden

The FACSCalibur is a flow cytometry system designed for multi-parameter analysis of cells and other particles. It features a blue (488 nm) and a red (635 nm) laser for excitation of fluorescent dyes. The instrument is capable of detecting forward scatter, side scatter, and up to four fluorescent parameters simultaneously.

Fetal bovine serum (fbs) by Thermo Fisher Scientific

Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal

Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.

Blood cell culture dna mini kit by Qiagen

Sourced in Germany, United States

The Blood & Cell Culture DNA Mini Kit is a laboratory equipment designed for the rapid and efficient extraction of high-quality genomic DNA from a variety of sample types, including whole blood, buffy coat, and cultured cells. The kit utilizes a simple and streamlined protocol to isolate DNA, making it suitable for a range of downstream applications.

Trizol reagent by Thermo Fisher Scientific

Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand

TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.

Ficoll paque plus by GE Healthcare

Sourced in Sweden, United States, United Kingdom, Germany, Canada, Japan, Italy, France, China, Austria, Switzerland, Belgium, Australia, Norway, New Zealand, Denmark, Finland, Spain, Georgia

Ficoll-Paque PLUS is a sterile, ready-to-use medium for the isolation of mononuclear cells from blood or bone marrow by density gradient centrifugation. It is a polysucrose and sodium diatrizoate solution with a density of 1.077 g/mL.

Penicillin streptomycin by Thermo Fisher Scientific

Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia

Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.

Facs lysing solution by BD

Sourced in United States, United Kingdom, Germany, Australia, Poland, Canada, Belgium

FACS lysing solution is a laboratory reagent used to prepare cell samples for flow cytometry analysis. It is designed to lyse red blood cells while preserving the integrity of the remaining cellular components, allowing for more accurate detection and analysis of specific cell populations.

Lsrfortessa by BD

Sourced in United States, United Kingdom, Germany, France, Australia, Canada, Belgium, China, Uruguay, Japan, Switzerland, Cameroon

The LSRFortessa is a flow cytometer designed for multiparameter analysis of cells and other particles. It features a compact design and offers a range of configurations to meet various research needs. The LSRFortessa provides high-resolution data acquisition and analysis capabilities.

Rpmi 1640 by Thermo Fisher Scientific

Sourced in United States, China, United Kingdom, Germany, France, Canada, Japan, Australia, Italy, Switzerland, Belgium, New Zealand, Austria, Netherlands, Israel, Sweden, Denmark, India, Ireland, Spain, Brazil, Norway, Argentina, Macao, Poland, Holy See (Vatican City State), Mexico, Hong Kong, Portugal, Cameroon

RPMI 1640 is a common cell culture medium used for the in vitro cultivation of a variety of cells, including human and animal cells. It provides a balanced salt solution and a source of essential nutrients and growth factors to support cell growth and proliferation.

What are the main types of blood cells and their functions?

The main types of blood cells are red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). Red blood cells are responsible for transporting oxygen and carbon dioxide throughout the body. White blood cells defend against infection and disease. Platelets are essential for blood clotting and wound healing. These cellular components work together to support the body's physiological processes.

What are some common challenges in working with blood cells?

Working with blood cells can present several challenges, such as maintaining cell viability, ensuring accurate cell counts, and preventing contamination. Researchers must also consider the heterogeneity of blood cell populations and the need for robust, reproducible protocols to obtain reliable results. Adressing these challenges is crucial for advancing our understanding of blood cell biology and improving clinical applications.

How can PubCompare.ai help with blood cell research?

PubCompare.ai can revolutionize blood cell research by helping researchers more efficiently screen protocol literature and leverage AI to pinpoint critical insights. The platform's AI-driven analysis can highlight key differences in protocol effectiveness, enabling researchers to identify the most effective protocols related to blood cells for their specific research goals. This can enhance the accuracy and productivity of blood cell research by helping researchers choose the best options for reproducibility and accuracy.

Are there different variations or types of blood cells that researchers should be aware of?

Yes, there are several variations and types of blood cells that researchers should be aware of. For example, within the white blood cell category, there are different subtypes such as neutrophils, lymphocytes, monocytes, eosinophils, and basophils, each with their own unique functions and characteristics. Researchers may need to consider these nuances when designing experiments and interpreting results related to blood cell biology.

How can PubCompare.ai assist in the optimal use and comparison of blood cell protocols?

PubCompare.ai can assist in the optimal use and comparison of blood cell protocols in several ways. The platfrom's AI-driven analysis can help researchers quickly identify the most effective and reproducible protocols from a vast body of literature, pre-prints, and patents. By highlighting key differences in protocol effectiveness, PubCompare.ai enables researchers to choose the best options for their specific research goals, enhancing the accuracy and productivity of their blood cell studies. This can be particularly useful when dealing with the heterogeneity of blood cell populations and the need for robust experimental approaches.

More about "Blood Cells"

Discover the power of blood cell research with PubCompare.ai, the AI-driven platform that revolutionizes this critical field of study.
Blood cells, also known as hematopoietic cells, are the cellular components of blood that play vital roles in the body's physiological processes.
These cells include red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes).
Red blood cells are responsible for transporting oxygen and carbon dioxide throughout the body, while white blood cells defend against infection and disease.
Platelets are essential for blood clotting and wound healing.
Researchers in the field of hemotology and hematopoeisis utilize advanced techniques and technologies, such as the FACSCanto II, FACSCalibur, and LSRFortessa flow cytometers, to study the structure, function, and development of these critical cellular components.
Accurate and reproducible protocols, such as those involving the Blood & Cell Culture DNA Mini Kit, TRIzol reagent, Ficoll-Paque PLUS, and FACS lysing solution, are crucial for advancing our understanding of blood cell biology and improving clinical applications.
By leveraging cutting-edge AI technology, PubCompare.ai helps you identify the best protocols and products, enhancing the accuracy and productivity of your blood cell research.
Whether you're studying erythrocytes, leukocytes, or thrombocytes, PubCompare.ai empowers you to locate the most accurate and reproducible protocols from literature, pre-prints, and patents with ease.
Experience the future of scientific discovery with PubCompare.ai and unlock the secrets of the blood cell universe.